Several clinical trials have demonstrated that supplementation with zeaxanthin and lutein improves visual function, attenuates VEGF-induced neovascularization in human retinal microvascular endothelial cells, and reduces the risk of progression to advanced AMD [185, 186]. This evidence concerns the gene VEGFA and age-related macular degeneration.